Bicycle Therapeutics (BCYC) insider trading in the last 6 months

5 insiders sold $112K. No buys.

Quality Score-4Poor

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 17 tradesSee it live, free for 24 hours. No account. No card. Then keep going with a free account.

Form 4 filings, newest first

SellKevin Lee$21KChief Executive Officerat $3.47 on Oct 2, filed Oct 6

SellKevin LeeChief Executive Officer$21Kat $3.47 on Oct 2, filed Oct 6

SellRobert Charles Swanton$12KDirectorat $3.47 on Oct 2, filed Oct 6

SellRobert Charles SwantonDirector$12Kat $3.47 on Oct 2, filed Oct 6

SellMichael Skynner$7KChief Scientific Officerat $3.47 on Oct 2, filed Oct 6

SellMichael SkynnerChief Scientific Officer$7Kat $3.47 on Oct 2, filed Oct 6

From SEC Form 4s, the newest filed Oct 6, 2026 · Insiders have 2 business days to file a trade

14 more filings on BCYC in the last 6 months, for Pro members. See them free →

Pro members see every filing on BCYC with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at Bicycle Therapeutics

Insider trades by person

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Questions about BCYC's insider trades

As of Nov 11, 2026: Bicycle Therapeutics (BCYC) has 17 insider filings on record in the last 6 months, the newest filed Oct 6, 2026. Its Quality Score is -4 (Poor). Scores as of 11:52 AM ET, 15 minutes behind.

Are BCYC insiders buying or selling?

5 insiders sold $112K across 17 filings in the last 6 months. No open-⁠market buys on record. The newest filing: Kevin Lee, Chief Executive Officer, sold $21K on Oct 2, 2026.

Who are BCYC's biggest insider sellers?

By the dollars of their sales in the last 6 months: Kevin Lee (Chief Executive Officer), 4 sales; Michael Skynner (Chief Scientific Officer), 4 sales; Michael Charles Ferguson Hannay (Chief Prod & Supply Chain Off), 4 sales. 5 insiders sold in all.

When did a BCYC insider last buy?

No BCYC insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by Kevin Lee on Oct 2, 2026.

Bicycle Therapeutics's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech.

Bicycle Therapeutics (BCYC) insider trading in the last 6 months

Form 4 filings, newest first

Who files at Bicycle Therapeutics

Questions about BCYC's insider trades

Every insider trade, with its stock's score.